PET-CT FDG: 700 USD
PET-CT Ga68 PSMA: 1700 USD
Full-Body MRI (3 Tesla): 900 USD
Stereotactic Radiosurgery (SRS): 4500 USD
Radiotherapy Treatment (Starts from): 4000 USD
Radioactive Iodine Therapy (Starts from): 3500 USD
Check-up (Starts from): 900 USD
Lu-177 PSMA Therapy: 9000 USD
Ac-225 PSMA Therapy (Starts from): 16000 USD
Brain Surgery (Starts from): 15000 USD
Breast Cancer Surgery (Starts from): 8000 USD
MIBG Scan (Starts from): 2500 USD
PET-CT FDG: 700 USD
PET-CT Ga68 PSMA: 1700 USD
Full-Body MRI (3 Tesla): 900 USD
Stereotactic Radiosurgery (SRS): 4500 USD
Radiotherapy Treatment (Starts from): 4000 USD
Radioactive Iodine Therapy (Starts from): 3500 USD
Check-up (Starts from): 900 USD
Lu-177 PSMA Therapy: 9000 USD
Ac-225 PSMA Therapy (Starts from): 16000 USD
Brain Surgery (Starts from): 15000 USD
Breast Cancer Surgery (Starts from): 8000 USD
MIBG Scan (Starts from): 2500 USD
An MIBG (Metaiodobenzylguanidine) scan is a specialized imaging procedure used primarily to detect and evaluate certain types of tumors, especially neuroendocrine tumors. This scan involves injecting a radioactive substance called iodine-123 or iodine-131 labeled MIBG into the bloodstream. MIBG naturally targets and accumulates in specific tumor cells, making them visible on a special camera during imaging.
Due to its specificity, the MIBG scan is often essential for the accurate diagnosis, staging, and treatment planning of neuroendocrine tumors such as pheochromocytomas and neuroblastomas.
The MIBG scan is particularly beneficial when dealing with specific types of tumors and health conditions. Key indications include:
A rare tumor of the adrenal glands characterized by excess hormone secretion, causing high blood pressure, rapid heart rate, and sweating. MIBG scans provide excellent sensitivity and specificity in identifying these tumors, locating both adrenal and extra-adrenal growths.
A cancer primarily affecting infants and young children, originating in nerve cells. The MIBG scan accurately detects the presence, spread, and response to treatment of neuroblastomas, guiding clinical decisions effectively.
Less common indications include evaluation of carcinoid tumors, particularly when they present diagnostic challenges or when conventional imaging has limitations.
Rare tumors originating from the nervous system, often hard to detect using standard imaging techniques. MIBG scans significantly enhance diagnostic precision in these cases.
MIBG scans provide high sensitivity for detecting specific tumors, particularly neuroblastomas and pheochromocytomas. It enables doctors to detect even small or otherwise hidden tumors that might escape conventional imaging techniques.
Unlike certain imaging methods limited to specific areas of the body, MIBG scans cover the entire body, identifying tumors and metastases in a single session, improving diagnosis and staging accuracy.
MIBG scans assist physicians in accurately determining tumor location and extent, directly influencing surgical, radiotherapy, or chemotherapy decisions. Regular scans can also monitor the effectiveness of treatments and detect recurrence early.
This imaging method is minimally invasive, requiring only an intravenous injection. Despite involving radioactive material, radiation exposure is minimal and typically safe, with manageable precautions.
Preparation is crucial to obtain accurate results from an MIBG scan. Typically, the patient is advised to:
Avoid certain medications that might interfere with the uptake of MIBG. Such medications include specific antidepressants, blood pressure medications, and cold or allergy medications.
Receive iodine tablets or drops to protect the thyroid gland from absorbing excess radioactive iodine.
Stay hydrated before and after the procedure to facilitate clearance of the radioactive substance from the body.
Injection: The patient receives an intravenous injection of radioactive MIBG.
Waiting Period: After the injection, the patient waits approximately 24 hours to allow the substance to concentrate within tumor cells.
Scanning: The patient lies still under a gamma camera, capturing detailed images of the body. The imaging typically lasts from 1 to 2 hours.
Follow-up: Occasionally, additional scans are performed at 48 hours to ensure optimal diagnostic accuracy.
MIBG scans are considered safe, but patients should be aware of minor risks, primarily linked to radiation exposure, which is kept minimal. Some individuals might experience minor reactions to the injection site or temporary fatigue. Pregnant women and breastfeeding mothers should discuss their conditions with their doctors before proceeding with the scan.
MIBG scans are indispensable diagnostic tools in managing neuroendocrine tumors, enabling precise detection, staging, and effective treatment planning. Understanding the procedure and its benefits helps patients actively participate in their treatment journeys, leading to improved outcomes and peace of mind.
WhatsApp us